groups » Global Health News, Events and Conferences » Ebola drug trial starts in Liberia - Brincidofovir
The trial of antiviral drug Brincidofovir is being tested in Liberia, in a trial led by Oxford University in collaboration with MSF research sites. Brincidofovir was chosen because it is effective against Ebola-infected cells in laboratories, has been deemed safe in more than 1,000 patients in trials against other viruses and can be given conveniently as a tablet. Researchers aim to recruit more than 100 people and will compare death rates at the centre before and after the trial.
The full story can be fiound at http://www.bbc.co.uk/news/health-30694998
Please Sign in (or Register) to view further.